John Townsend
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
John W.
Townsend is Chief Financial Officer at Unicycive Therapeutics, Inc. since 2021.
Formerly, Mr. Townsend was Chief Accounting Officer at Plus Therapeutics, Inc. in 2015.
From 2017 to 2020, Mr. Townsend was Chief Accounting Officer & Controller at Guardion Health Sciences, Inc. Mr. Townsend completed an undergraduate degree at San Diego State University in 1993.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.03.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| GUARDION HEALTH SCIENCES, INC. | Comptroller/Controller/Auditor | 02.09.2020 |
| PLUS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30.06.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc. Pharmaceuticals: OtherHealth Technology Develops and distributes food & dietary supplements | Health Technology |
Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen